Guanze Medical (02427) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend

Bulletin Express03-18 18:40

Guanze Medical Information Industry (Holding) Co., Ltd. (stock code: 02427) has announced that its board of directors will convene on Tuesday, 31 March 2026.

The meeting agenda includes: 1. Reviewing and, if deemed appropriate, approving the audited annual results for the financial year ended 31 December 2025. 2. Considering the declaration of a final dividend for FY2025. 3. Addressing any other business matters.

Chairman Meng Xianzhen issued the notice on 18 March 2026. The board currently comprises Executive Directors Meng Xianzhen and Guo Zhenyu; Non-Executive Director Meng Cathy; and Independent Non-Executive Directors Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.

The announcement reiterates that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the content’s accuracy or completeness.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment